Wells Fargo analyst Larry Biegelsen maintains $GE HealthCare Technologies (GEHC.US)$ with a buy rating, and maintains the target price at $95.
According to TipRanks data, the analyst has a success rate of 64.8% and a total average return of 11.2% over the past year.
Furthermore, according to the comprehensive report, the opinions of $GE HealthCare Technologies (GEHC.US)$'s main analysts recently are as follows:
GE HealthCare shares have experienced a 20% increase year-to-date and are approaching all-time highs, currently trading at a premium relative to a close peer. This premium is challenging to justify considering GE HealthCare's relatively lower growth outlook, suggesting that investor expectations may exceed even sell-side consensus. In this context, it is anticipated that GE's growth in the near to medium term may not meet expectations.
GE HealthCare has received positive news from the FDA with the approval of Flurpiridaz, a novel myocardial perfusion imaging positron emission tomography radiopharmaceutical. This product stands out because it is offered as an 'individual dose' prepared in advance, which is a departure from the current standard of on-site dose manufacturing. According to analyst research, Flurpiridaz is expected to deliver significant clinical enhancements over existing MPI radiopharmaceuticals. It is anticipated that adoption by current U.S. cardiac PET centers will be swift and that the availability of Flurpiridaz will substantially widen the reach of U.S. cardiac PET imaging.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
